An evidence-aware look at urolithin A, a gut-derived metabolite with human muscle and endurance data, sold as a well-tolerated supplement.
At a glance
Urolithin A is a metabolite the gut microbiome produces from ellagitannins found in foods like pomegranates, berries, and walnuts. Not everyone's gut bacteria make it efficiently, which is why it is sold as a direct supplement, most recognisably under the branded ingredient Mitopure. Its headline mechanism is mitophagy - the cellular recycling of worn-out mitochondria - and unlike most compounds in this space it has actual randomised human data.
This is an educational tracking guide, not a recommendation. Urolithin A is a comparatively low-risk supplement, but that does not mean the effects are dramatic.
It is commonly taken as a single daily oral dose with food, run continuously over months rather than cycled, because the benefits are gradual adaptations rather than acute effects. This is a described pattern, not a dose recommendation.
This is a slow, quiet compound. The human data supports better muscle endurance and mitochondrial function over months, not a noticeable acute lift. If you expect to feel something the first week, you will conclude it does nothing. Judge it on a benchmark measured over a quarter.
Urolithin A has been well tolerated in human trials with a reassuring safety profile, which puts it among the lower-risk compounds discussed here. That said, supplement quality varies, long-term data is still accumulating, and anyone with a medical condition or on medication should still check with a clinician before starting. Well tolerated is not the same as guaranteed effective for your goal.
Peptid AI is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.